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Abstract
Nervous tissue is characterized by a tight structural association between glial cells and neurons. It
is well known that glial cells support neuronal functions, but their role under pathologic conditions
is less well understood. Here, we addressed this question in vivo using an experimental model of
retinal ischemia and transgenic mice for glia-specific inhibition of soluble N-ethylmaleimide-sensi-
tive factor attachment protein receptor (SNARE)-dependent exocytosis. Transgene expression
reduced glutamate, but not ATP release from single M€uller cells, impaired glial volume regulation
under normal conditions and reduced neuronal dysfunction and death in the inner retina during
the early stages of ischemia. Our study reveals that the SNARE-dependent exocytosis in glial cells
contributes to neurotoxicity during ischemia in vivo and suggests glial exocytosis as a target for
therapeutic approaches.
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1 | INTRODUCTION
Neuroglial cells such as astrocytes and retinal M€uller cells not only fill
the space between neurons but they represent essential partners.
Under normal conditions, they support neuronal function in different
ways including potassium buffering, transmitter uptake and the provi-
sion of energy substrates (Bringmann et al., 2006; Parpura et al., 2012).
Their role under pathologic conditions caused by mutations, ischemia
or injuries is less well understood, they may exacerbate or mitigate
neuronal damage. Extracellular accumulation of glutamate, the major
neurotransmitter in the CNS, damages neurons in different pathologies
including ischemia (Brassai, Suvanjeiev, Ban, & Lakatos, 2015; Osborne
et al., 2004), but the contribution of glial cells remains unclear (Rossi &
Volterra, 2009). Under normal conditions, glial cells control the
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extracellular glutamate concentration by electrogenic glutamate trans-
porters (Bringmann et al., 2013; Grewer & Rauen, 2005; Rauen, 2000).
Consequently, an impairment of glial glutamate uptake for example
due to accumulation of extracellular potassium (Billups & Attwell,
1996; Maguire, Simko, Weinreb, & Ayoub, 1998; Rossi, Oshima, & Att-
well, 2000; Szatkowski, Barbour, & Attwell, 1990) could cause loss of
neurons (Rossi, Brady, & Mohr, 2007).
Studies within the last decade have shown that glial cells can
release transmitters (which are called gliotransmitters) in a calcium- and
soluble N-ethylmaleimide-sensitive factor attachment protein receptor
(SNARE)-dependent manner (Marchaland et al., 2008; Martineau,
2013; Montana, Malarkey, Verderio, Matteoli, & Parpura, 2006; Slezak
et al., 2012). The physiologic relevance of this process is debated: it
may contribute to glial volume regulation (Slezak et al., 2012) and mod-
ulate neuronal activity (Araque et al., 2014; Chen et al., 2012; Perez-
Alvarez, Navarrete, Covelo, Martin, & Araque, 2014; Takata et al.,
2011). Here, we studied the contribution of glial SNARE-dependent
exocytosis to neurodegeneration in the retina. To this end, we used an
established model of transient ischemia that triggers robust neuronal
dysfunction and degeneration (Osborne et al., 2004; Pannicke et al.,
2014). To interfere with glial exocytosis, we used a mouse line enabling
inducible expression of a dominant-negative domain of synaptobrevin
(dnSNARE mice; Pascual et al., 2005). Our results reveal that glia-
specific inhibition of SNARE-dependent signaling protects retinal neu-
rons from dysfunction and degeneration.
2 | MATERIALS AND METHODS
2.1 | Materials
All substances were purchased from Sigma-Aldrich (Taufkirchen, Ger-
many) unless stated otherwise. Papain was obtained from Roche (Mann-
heim, Germany). Chloromethyl-tetramethyl-rosamine (Mitotracker
Orange), NP-EGTA (o-nitrophenyl EGTA), NPE-ATP (P(3)-[1-(2-nitro-
phenyl)]ethyl ester of ATP), and Fluo-4 AMwere fromMolecular Probes
(Life Technologies, Carlsbad, CA). For immunocyto- and histochemical
staining, the following primary antibodies were used: rabbit anti-Kir4.1
(1:200; Sigma-Aldrich), mouse anti-glial fibrillary acidic protein (GFAP;
1:200; G-A-5 clone, Sigma-Aldrich), goat anti-calretinin (1:500, Swant,
Marly, Switzerland), mouse anti-calbindin (1:400, Swant), rabbit anti-
PKCa (1:300, Santa Cruz Biotechnology, Heidelberg, Germany), rabbit
anti-cellular retinaldehyde-binding protein (CRALBP; 1:300, Santa Cruz),
rabbit-anti-Iba1 (1:500, Wako Chemicals, Neuss, Germany), and mouse
anti-glutamine synthetase (1:1000, Merck Millipore, Darmstadt, Ger-
many). As secondary antibodies, we used Cy5-conjugated donkey anti-
goat, Cy3-conjugated donkey anti-rabbit, Cy2-conjugated donkey anti-
mouse, Cy3-conjugated goat anti-rabbit, and Cy2-conjugated goat anti-
mouse. All secondary antibodies were obtained from Dianova (Ham-
burg, Germany) and applied at 1:200 dilution. Apoptosis was detected
by the in situ cell death detection kit (Roche, Mannheim, Germany).
2.2 | Animals
All experiments were performed in accordance with the European
Community Council Directive 2010/63/EU after approval by the local
authorities (TVV 54/12 approved by the state directorate Leipzig). Ani-
mals were maintained with free access to water and food in an air-
conditioned room on a 12-hr light-dark cycle. Transgenic dnSNARE
mice were bred as described earlier (Pascual et al., 2005). These mice
use the Tet-Off system to express a dominant negative subdomain of
synaptobrevin (VAMP2) and enhanced green fluorescent protein
(EGFP) under the control of a human GFAP promoter fragment. To
prevent transgene expression during development, the animals
received doxycycline until weaning (25 lg/ml in drinking water).
Homozygous mice deficient in the nucleotide receptor P2Y1 (P2Y1R-
KO, 3–5 months old; Fabre et al., 1999) and wildtype littermates were
genotyped according to Pannicke et al. (2014).
2.3 | Measurement of transmitter release in single
M€uller cells
Transmitter release from acutely isolated M€uller cells was measured
using a fluorimetric enzyme assay as described (Slezak et al., 2012).
Briefly, retinae were treated with papain (0.2 mg/ml; Roche Molecular
Biochemicals) for 30 min at 378C in the dark in Ca21- and Mg21-free
extracellular solution (140 mM NaCl, 3 mM KCl, 10 mM HEPES,
11 mM glucose, pH 7.4). Before detecting glutamate release, glutamine
(0.25 mM) and glutamate (0.5 mM) were supplemented to maintain
high intracellular glutamate levels. After several washes, retinae were
triturated in extracellular solution (with 1 mM MgCl2 and 2 mM CaCl2)
containing all components of the Amplex® Red Glutamic Acid kit, D,L-
threo-beta-benzyloxyaspartate (TBOA, 200 mM) to block glial gluta-
mate uptake and NP-EGTA (10 mM) or NPE-ATP at varying concentra-
tions. Subsequently, the cell suspension was mixed with 1.5% agarose
and incubated for 30 min in the recording chamber at 378C. At each
recording session, we measured cells from one wild type mouse and
one dnSNARE mouse using the same assay solution freshly prepared
for the actual experiment. This rules out confounding effects of differ-
ences in the assay composition. If blockers were tested, they were co-
applied with the gel-enzyme-mixture and also preincubated for 30 min.
The combination of enzymes generates H2O2 only in the presence of
glutamate. H2O2 together with Amplex® Red serve as substrates for
horseradish peroxidase to generate resorufin. Resorufin fluorescence
was detected with a confocal laser microscope (LSM510 Meta, 1003/
1.3 Plan-Neofluar oil, Zeiss, Oberkochen, Germany; 543 nm helium-
neon laser, 585 nm long pass filter, pinhole maximally open). Images
were taken from the endfeet of M€uller cells, which were identified
based on their unique morphology. To detect ATP release, glutamate-
specific enzymes (L-glutamate oxidase, L-glutamate–pyruvate transami-
nase), TBOA, and alanine were replaced by glycerol kinase (10 U/ml),
glycerol-3-phosphate oxidase (10 U/ml) and glycerol (500 mM) from
the Amplex® Red assay. The combination of enzymes and substrates
generates H2O2 (and finally resorufin) only in the presence of ATP
(Dale & Frenguelli, 2012).
To trigger calcium-dependent release, intracellular calcium rises
were induced by four UV-pulses (351 nm/364 nm Enterprise UV Laser,
500 ms at maximal intensity) to uncage calcium from NP-EGTA or to
release ATP from NPE-ATP. Peak amplitudes were calculated as
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difference between mean fluorescence intensity across four time
points acquired before and after the UV pulses. To validate
concentration-dependent detection of glutamate or ATP, we per-
formed the enzymatic assay under cell-free conditions. To detect gluta-
mate, extracellular solution with all enzymatic components of the
Amplex® Red Glutamic Acid kit, TBOA (200 mM), and 1.5% agarose
but without cells was filled into the recording chamber. Extracellular
solution containing defined concentrations of glutamate was added to
the recording chamber. Similarly, we validated the ATP detection assay
using a similar procedure, but implementing glycerol kinase, glycerol-3-
phosphate oxidase and glycerol. We recorded resorufin fluorescence
under cell-free conditions on a microplate reader (HTS7000 Bio Assay
Reader Perkin-Elmer, Rodgau J€ugesheim, Germany).
2.4 | Calcium measurements in single M€uller cells
Cells were isolated as described for the measurements of transmitter
release and incubated with Fluo4 AM (1 mM) and with or without NP-
EGTA and NPE-ATP. ATP was applied by slow perfusion (600 ml/min)
to induce calcium transients or by photolysis of NPE-ATP as described
for glutamate release experiments. The uncaging protocols are
described in the figure legends (Figure 2).
2.5 | Calcium measurements on retinal whole-mounts
Retinae were prepared from male mice (P23–P90, C57BL/6) and trans-
ferred onto a net-insert in a microdish filled with 1 ml artificial cerebro-
spinal fluid (ACSF) containing in mM: 125 NaCl, 26 NaHCO3, 1.25
NaH2PO4, 20 glucose, 2.5 KCl, 1 MgCl2, and 2 CaCl2. The solution was
aerated with carbogen (95%O2, 5% CO2). Whole-mounts were incu-
bated in the dark for 1 hr at room temperature (228C) with the fluores-
cent calcium indicator Fluo-4 AM (15 mM, Invitrogen, Carlsbad, CA)
added to the ACSF to selectively load M€uller cells. VEGF (30 ng/ml)
was bath-applied in a closed perfusion circuit with a total volume of
14 ml. For calcium imaging the whole-mount was transferred to a sub-
merged chamber perfused with ACSF and held in place by a nylon grid
with the ganglion cell layer (GCL) facing toward the water immersion
objective (NA 1.0; Nikon Instruments, Tokyo, Japan). Retinal cells were
visualized by gradient contrast using a Femto-2D-uncage microscope
(Femtonics, Budapest, Hungary) controlled by MES v4.5.613 software
(Femtonics). A tunable, Verdi-pumped Ti:Sa laser (Chameleon Ultra,
Coherent, Santa Clara, CA) was used for excitation of Fluo-4 AM at
840 nm. Green fluorescence images were collected both in the epi-
and transfluorescence mode. M€uller cell endfeet (MCE) were imaged in
frame scan mode for 2 min (rate: 20 Hz; size: 40 3 83 mm correspond-
ing to 9 endfeet; image resolution: 1.6 mm per pixel. For the quantita-
tive analysis, endfeet of M€uller cells were marked as region of interest
(ROI). Average or integral of pixels in these ROIs were averaged and
changes in calcium were measured as DF/F and compared between dif-
ferent conditions. Control experiments included consecutive frame
scans without drug application. Offline data analysis was performed
using custom macros written in IGOR Pro (Wavemetrics, Lake Oswego,
OR) and MES (Femtonics) and custom MATLAB (MathWorks, Ismaning,
Germany) scripts.
2.6 | Retinal ischemia
The high intraocular pressure (HIOP) method was used to induce tran-
sient ischemia in the retina as reported (Pannicke et al., 2014). Briefly,
animals were anesthetized by intraperitoneal (ip) injections of ketamine
(100 mg/kg body weight; Ratiopharm, Ulm, Germany), xylazine (5 mg/
kg; Bayer Vital, Leverkusen, Germany), and atropine sulfate (100 mg/
kg; Braun, Melsungen; Germany). The anterior chamber of one eye was
cannulated from the pars plana by a 30-gauge infusion needle con-
nected to Deltajonin® (Deltaselect, Dreieich, Germany) bottle. The
contralateral eye remained untreated and served as control. To inter-
rupt retinal blood supply, the intraocular pressure was raised to
160 mm Hg for 90 min by elevating the bottle. Animals were sacrificed
14 hr, 1 or 7 days postoperation with carbon dioxide.
2.7 | Volume regulation
Volume changes in retinal M€uller cells were measured as described
(Slezak et al., 2012). Briefly, retinal slices were loaded with the vital dye
Mitotracker Orange (10 mM, excitation: 543 nm, emission: 560 nm
long-pass filter; Life Technologies), which is preferentially taken up by
M€uller cells (Uckermann et al., 2004). Slices were exposed to hypotonic
solution (60% of control osmolarity using distilled water) for 4 min with
or without test substances. Somata of labelled M€uller cells were
imaged using confocal microscopy (LSM 510 Meta, Zeiss, Oberkochen,
Germany) and their cross-sectional areas were measured (Zeiss LSM
Image Examiner Version 3.2.0.70). In dnSNARE mice, EGFP1 and
EGFP- cells were imaged and analyzed separately (excitation: 488 nm;
emission: 505 nm long-pass filter).
2.8 | Histological and immunohistochemical staining
Retinae were immersion-fixed (4% paraformaldehyde for 2 hr), washed
with phosphate-buffered saline (PBS), embedded in PBS containing 3%
agarose (w/v) and cut in 70 mm thick sections using a vibratome. Reti-
nal sections were permeabilized (0.3% Triton X-100 plus 1.0% DMSO
in PBS) and blocked (5% normal goat serum with 0.3% Triton X-100
and 1.0% DMSO in PBS) for 2 hr at room temperature. Primary anti-
bodies were incubated overnight at 48C. Sections were washed (1%
bovine serum albumin in PBS) and incubated with secondary antibodies
(2 hr at room temperature). Cell nuclei were labeled with TO-PRO-3
(1:1000; Life Technologies). Retinal whole-mounts were labeled using a
similar protocol, except that tissue was permeabilized by higher con-
centrations of Triton X-100 and DMSO (0.3% Triton X-100 plus 1.0%
DMSO in PBS) and secondary antibodies were also incubated at 48C
overnight. Control experiments without primary antibodies showed no
unspecific labeling except for the goat-anti-mouse secondary antibody
which labeled blood vessels (not shown). Images were acquired using
confocal microscopy (LSM 510 Meta, Zeiss). Cell nuclei were counted
in three retinal layers in 100 mm-wide areas of the central retina close
to the optic nerve head (optical slice thickness, 1.5 mm). The TUNEL
assay was performed according to the manufacturer’s protocol (Roche
Molecular Biochemicals). Free-floating retinal sections were subjected
to a brief microwave treatment in citrate buffer (pH 6.0, 0.1 M) to
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enhance tissue penetration. After several washing steps, sections were per-
meabilized (10 min in 4% Triton X-100), incubated in the labeling solution
(90 min), counterstained with TO-PRO-3 and mounted on glass slides.
2.9 | Magnetic-activated cell sorting of retinal cells
M€uller cells were enriched as described (Grosche et al., 2016). Briefly,
retinae were digested as described above, incubated with DNase I (200
U/ml), and triturated in extracellular solution containing (mM) 135
NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 1 Na2HPO4, 10 HEPES, and 11 glucose
adjusted to pH 7.4 with Tris. After centrifugation, cells were resus-
pended and incubated in extracellular solution containing biotinylated
hamster anti-CD29 (clone Ha2/5, 0.1 mg/ml, BD Biosciences, Heidel-
berg, Germany) for 15 min at 48C. Cells were washed in extracellular
solution, spun down, resuspended in the presence of anti-biotin
MicroBeads (1: 5; Miltenyi Biotec, Bergisch Gladbach, Germany) and
incubated for 10 min at 48C. After washing, CD291 M€uller cells were
separated using large cell columns according to the manufacturer’s
instructions (Miltenyi Biotec). To select microglial cells in addition to
M€uller cells, the retinal suspension was incubated prior to M€uller cell
selection with CD11b-microbeads (Miltenyi Biotec) for 15 min at 48C
and microglia were depleted using LS-columns (Miltenyi Biotec). To
quantify cell enrichment, 50 ml of each sample were fixed (4% parafor-
maldehyde), washed in PBS and deposited on a glass slide. Dried sam-
ples were encircled with a PAP pen and subjected to nuclear and
immunocytochemical staining using an antibody against glutamine syn-
thetase. M€uller cells were identified by the presence of glutamine syn-
thetase and their morphology. Their percentage compared with total
count of cell nuclei was determined for respective cell populations.
2.10 | qRT-PCR
Total RNA was isolated from whole retinae and from enriched cell pop-
ulations using the RNeasy Micro Kit (Qiagen, Hilden, Germany). A
DNase digestion step was included to remove genomic DNA (Roche).
First-strand cDNAs from 50 ng of total RNA were synthesized using
the RevertAid H Minus First-Strand cDNA Synthesis Kit (Fermentas by
Thermo Fisher Scientific, Schwerte, Germany). Primers were desgined
using the Universal ProbeLibrary Assay Design Center (Roche). The pri-
mers to detect dnSNARE expression covered partially the sequence of
the dnSNARE domain and the SV40 polyA tail of the expression con-
struct. Transcript levels of candidate genes were measured by qRT-
PCR using cDNA with the TaqMan hPSC ScorecardTM Panel (384 well,
ViiA7, Life Technologies, Darmstadt, Germany) according to the com-
pany’s guidelines and its cloud-based online analysis software.
2.11 | Full-field electroretinography
Mice were dark adapted for at least 12 hr before recordings and anes-
thetized by subcutaneous injection of ketamine (65 mg/kg) and xyla-
zine (13 mg/kg). Pupils were dilated with tropicamide eyedrops
(Mydriaticum Stulln; Pharma Stulln). Silver needle electrodes served as
reference (forehead) and ground (tail) and gold wire ring electrodes as
active electrodes. Corneregel (Bausch & Lomb, Berlin, Germany) was
applied to keep the eye hydrated and to maintain good electrical con-
tact. ERGs were recorded using a Ganzfeld bowl (Ganzfeld QC450
SCX, Roland Consult, Brandenburg, Germany) and an amplifier with a
recording unit (RETI-Port, Roland Consult). ERGs were recorded from
both eyes simultaneously, band-pass filtered (1–300 Hz) and averaged.
Single flash scotopic (dark adapted) responses to a series of ten LED-
flash intensities ranging from 23.5 to 1.0 log cd.s/m2 with an intersti-
mulus interval of 2 up to 20 s for the highest intensity were recorded.
After 10 min of adaptation to a white background illumination (20 cd/
m2) single flash photopic (light adapted) responses to three Xenon-flash
intensities (1, 2, and 3 log cd.s/m2) were recorded. Responses were
quantified based on mean waveform peak amplitude and implicit time.
All analysis and plotting was carried out with R 3.2.1 (The R Foundation
for Statistical Computing) and ggplot2 2.1.0.
2.12 | Statistics
All data are expressed as mean6 standard error (SEM) unless stated
otherwise. Statistical analyses were performed using Prism (Graphpad
Software, San Diego, CA). Unless stated otherwise the significance was
determined by the nonparametric Mann-Whitney U test.
3 | RESULTS
3.1 | Validation of glia-specific dnSNARE expression
and its impact on transmitter release and volume
regulation in M€uller cells
We first examined the expression of the dnSNARE transgene and its
impact on M€uller cells using different approaches. Immunohistochemi-
cal staining of retinal sections and whole-mounts from transgenic mice
revealed expression of EGFP in M€uller cells and astrocytes, but not in
neurons or microglial cells (Figure 1a,b). We investigated whether
dnSNARE expression impacted the calcium-induced release of the glio-
transmitters glutamate and ATP in single acutely isolated M€uller cells
using enzymatic assays (Slezak et al., 2012). UV photolysis-induced cal-
cium transients evoked the release of glutamate from M€uller cells iso-
lated from wildtype mice after loading with the photolabile chelator
NP-EGTA. In M€uller cells from transgenic mice, the release was signifi-
cantly reduced (Figure 2a), whereas the size and kinetics of UV-
induced calcium transients were similar in cells from both genotypes
(Figure 2b) indicating a direct effect of dnSNARE on the release of glu-
tamate. Control experiments confirmed the microfluorimetric detection
of glutamate, the absence of NP-EGTA-independent release and side
effects due to UV exposure (Figure 2a,c,d).
Since photolysis of NP-EGTA may induce nonphysiological levels
of intracellular calcium, we tested next, whether extracellular ATP trig-
gers purinergic receptor-dependent glutamate release from M€uller glia
as observed previously in astrocytes (Domercq et al., 2006; Jourdain
et al., 2007). Photolysis of caged ATP caused a P2Y1 receptor-
dependent release of glutamate from M€uller cells: it was attenuated by
the P2Y1 antagonist MRS2179 (30 mM) and it was reduced in M€uller
cells isolated from P2Y1 KOmice (Figure 2e,f). M€uller cells from dnSNARE
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mice showed reduced P2Y-dependent glutamate release but calcium tran-
sients similar to those fromwildtype controls (Figures 2g and 6).
Previous findings showing SNARE-dependent ATP release from
astrocytes prompted us to establish a modified enzymatic assay to
detect ATP release from M€uller cells (Figure 3a). UV light induced equal
ATP signals in cells from wildtype and dnSNARE mice whereas removal
of the respective enzymes prevented the ATP signals (Figure 3b,c).
Addition of the connexin hemichannel blockers, 18-a-glycyrrhetinic
acid (50 mM) and carbenoxolone (CBX) (200 mM) significantly reduced
the ATP signals. The data suggest that ATP is released from M€uller cells
in a SNARE-independent manner, probably via hemichannels.
Next, we tested how the dnSNARE transgene affected volume
regulation in M€uller cells. Previous studies revealed that this process
relies on a VEGF-triggered signaling pathway comprising calcium-
dependent glutamate release, metabotropic glutamate receptors and
the nonvesicular release of ATP and adenosine (Br€uckner et al., 2012;
Slezak et al., 2012; Wurm, Pannicke, Wiedemann, Reichenbach, &
Bringmann, 2008). As shown in Figure 4a, superfusion with hypoos-
motic solution increased the soma size of M€uller cells expressing EGFP
and dnSNARE, but not of cells from wildtype mice or of EGFP-negative
cells from transgenic mice. The size change in EGFP-positive cells was
abolished by glutamate, ATP and adenosine, but not by VEGF as
expected because the latter acts upstream of the glutamate release.
Control experiments on M€uller cells from wildtype mice confirmed that
these compounds compensated the volume increase in hypoosmotic
solution induced by barium-block of inwardly rectifying potassium
channels (Figure 4b). Microfluorimetry of retinal whole-mounts loaded
with the calcium indicator Fluo-4 AM revealed that VEGF enhances
the calcium concentration in M€uller cells. VEGF was used at the same
concentration that prevented barium-induced swelling in wildtype
M€uller cells by inducing glutamate release (Figure 4c).
Taken together, these results validated that dnSNARE expression
in the retina was specific to M€uller cells, that it inhibited a fraction of
their calcium-dependent glutamate release but not of their calcium-
dependent ATP release, and that it impaired their volume regulation.
3.2 | Ischemia-induced changes in retinal M€uller cells
To determine whether and how calcium-dependent release from
M€uller cells contributes to pathologic changes ensuing transient
FIGURE 1 Validation of glia-specific transgene expression in retinae of dnSNARE mice. Immunohistochemical staining of retinal slices (a)
and whole-mounts (b) demonstrating exclusive EGFP expression as reporter for dnSNARE transgene expression in astrocytes and M€uller
cells. (a) Micrographs of retinal slices showing EGFP-positive glial cells, protein kinase Ca (PKCa)-positive rod bipolar cells and
neurofilament-positive neuronal fibers of the inner retina. Cell nuclei were labeled by DAPI. (b) Micrographs of retinal whole-mounts show-
ing Iba1-positive microglial cells and EGFP- and GFAP-positive astrocytes. Note labelling of vessels in the GFAP channel due to unspecific
binding of the secondary antibody. GCL5 ganglion cell layer; IPL5 inner plexiform layer; INL5 inner nuclear layer; ONL5outer nuclear
layer; OPL5outer plexiform layer. Scale bars, 20 mm [Color figure can be viewed at wileyonlinelibrary.com]
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ischemia, we subjected transgenic and wildtype mice to an ischemia/
reperfusion model, where retinal blood flow is blocked for 90 min by
experimentally raised intra-ocular pressure (Pannicke et al., 2014). As a
first step, we examined how M€uller cells react to transient ischemia.
Seven days after transient ischemia, dnSNARE mice showed a strongly
increased density of EGFP-positive M€uller cells (7166% of all M€uller
cells; n56 animals) compared with nonoperated dnSNARE mice (436
7%; n56 animals). This change was probably caused by ischemia-
induced activation of the GFAP promoter. Indeed, immunohistochemi-
cal staining revealed a strong postischemic increase of GFAP expres-
sion in retinae from both wildtype and dnSNARE mice (Figure 5a). This
was further confirmed by PCR analysis of selected transcripts in
enriched glial and neuronal cell preparations from retinae of wildtype
and transgenic mice. The glial population, which consisted mainly of
glutamine-synthetase positive M€uller cells (Figure 5b), showed strongly
increased levels of the tTA (tetracycline transactivator), EGFP and
SNARE transgene, whose expression is controled by the human GFAP
promoter (Figure 5a). Notably, these transgenes were absent from
FIGURE 2 Impact of dnSNARE expression on the glial calcium response and glutamate release. (a) Left, traces of glutamate release induced
by calcium uncaging via four consecutive UV flashes measured above the endfoot of a single M€uller cell from a wildtype and a dnSNARE
mouse. Right, calcium-induced glutamate release in M€uller cells in transgenic compared with wildtype mice. No signal was detected in the
absence of NP-EGTA or glutamate-specific enzymes (EC5 enzyme control) (n543–55 cells from 4 animals per genotype). Inset, EGFP-
positive M€uller cell. The open arrow points at the soma, while the filled arrow marks the M€uller cell endfoot. Scale bar, 10 mm. Compared
with measurements in the absence of NP-EGTA, but with all enzymes included: ···p< .001. (b) Mean microfluorimetric traces (left; n56 cells
each) and average sizes (right; n512–16 cells; 2 animals per genotype) of calcium increase in isolated M€uller cells from wildtype and
dnSNARE mice after a single UV flash uncaging calcium from NP-EGTA. (c) Enzyme- (EC, no glutamate-specific enzymes) and
concentration-dependent increase of glutamate-induced resorufin fluorescence indicating the sensitivity of the microfluorometric assay.
Bars represent mean6 SEM from 7 to 12 measurements from two independent preparations. *p< .05, **p< .01. (d) Traces showing tran-
sient increase in intracellular calcium after UV-induced photolysis in the presence, but not in the absence of NP-EGTA in acutely isolated
M€uller cells measured by Fluo-4 AM (n56). Control experiments revealed no UV-induced calcium transients in the absence of NP-EGTA
(n56) and proved cell viability as ATP (200 mM) induced calcium responses in M€uller cells after UV photolysis. (e) Mean calcium concentra-
tion in isolated M€uller cells before and after UV-induced uncaging of ATP (100 mM, 4 consecutive UV flashes) in the absence (n58 cells) or
presence of the P2Y1 receptor blocker MRS2179 (30 mM, n57 cells). Compared with measurements in the absence of MRS2179:
***p< .001, **p< .01, *p< .05. (f) Mean size of ATP-induced glutamate release at different concentrations of NPE-ATP (n510 cells from 2
mice), in P2Y1R-KO mice or in the presence of the P2Y1 receptor antagonist MRS2500 (MRS, 10 nM) (n515–20 cells from 2 to 3 animals).
(g) Mean ATP-induced glutamate release (4 consecutive UV flashes) in M€uller cells from dnSNARE and wildtype mice (n557–59 cells from
5 animals). ***p< .001: ADU5 arbitrary digital unit [Color figure can be viewed at wileyonlinelibrary.com]
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retinal neurons isolated from transgenic mice confirming their glia-
specific expression. We observed 67 (6 15.5)-fold higher levels of
dnSNARE transcripts in M€uller cells compared with neurons, whereas
the well-established M€uller cell marker glutamine synthetase or Kir4.1
were only enriched by 18.1 (6 4.8)-fold or 4.8 (6 1.7)-fold, respec-
tively, demonstrating robust transgene-expression in retinal M€uller cells
(Figure 5b). Ischemia-induced activation of the GFAP promoter was
further confirmed by a parallel increase of endogenous GFAP
FIGURE 3 Release of ATP is unaltered in dnSNARE mice. (a) ATP could be detected in a concentration-dependent manner based on resorufin
fluorescence in the modified enzymatic assay as determined by cell-free measurements on a microplate reader. No or significantly smaller sig-
nals were detected in the absence of ATP or ATP-specific enzymes (EC5 enzyme control). Values represent mean6 SEM from 4 independent
experiments. (b) Increase in ATP release following UV-induced photolysis of NP-EGTA in M€uller cells from wildtype (Wt, n57 cells) and
dnSNARE mice (n57 cells). No ATP signal was observed after the removal of the ATP-specific enzymes. Insets: micrographs showing resorufin
fluorescence above a M€uller cell endfoot (demarcated by dashed line) before and after the UV pulse. (c) Calcium-induced ATP release in M€uller
cells from wildtype (Wt) and dnSNARE mice. No signal was detected in the absence of NP-EGTA or ATP-specific enzymes (EC5 enzyme con-
trol) (n57–11 cells from 2 animals of each genotype). Compared with measurements in the absence of NP-EGTA, but with all enzymes
included: *** p< .001. (d) NP-EGTA-induced ATP release in the presence or absence of 18-a-glycyrrhetinic acid (18aGA, 50 mM) and CBX (200
mM) (n510–15 cells). Compared with measurements in the absence of NP-EGTA: ***p< .001. · p< .05, ·· p< .01 [Color figure can be viewed at
wileyonlinelibrary.com]
FIGURE 4 Effect of dnSNARE expression on M€uller cell volume regulation. (a, b) The soma area of each cell after 4 min of exposure to
hypoosmolar solution was normalized to its size in isoosmolar solution (n59–15 cells from 2 to 3 mice per genotype). (a) EGFP- M€uller
cells showed no increase in soma size whereas EGFP1 cells swelled under hypoosmotic conditions. Glutamate (1 mM), ATP (200 mM), and
adenosine (10 mM), but not VEGF (10 ng/ml) restored the volume regulation of dnSNARE-expressing cells. Insets, M€uller cells from wildtype
mice labeled by Mitotracker Orange (10 mM, left) and from transgenic mice expressing EGFP (right). Scale bars, 5 mm. Compared with meas-
urements of M€uller cell soma area in wildtype retinae: ···p< .001. (b) Area of M€uller cell somata in retinal slices from wildtype mice chal-
lenged by hypoosmotic solution in the presence of 1 mM barium. All applied compounds restored volume regulation. Compared with soma
area of wildtype M€uller cells in the absence of barium ions: ···p< .001. (c) Left, top, Changes in the Fluo-4 AM fluorescence were recorded
from the area delineated by the rectangle. Dashed lines mark single MCE. BV5 blood vessel. Left, bottom, representative traces of calcium
transients in MCE of retinal whole-mount preparations from wildtype mice demonstrate VEGF-induced rises in intracellular calcium (red
trace). Right, calcium concentration in M€uller cells (control: n552 cells from 2 mice; VEGF: n581 cells from 8 mice). ***p< .001, **p< .01,
*p< .05. Data are represented as mean6 SEM [Color figure can be viewed at wileyonlinelibrary.com]
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transcripts in transgenic and wildtype mice. The levels of glutamine
synthetase and Kir4.1 were only transiently decreased. Interestingly,
rhodopsin transcripts were expressed in the neuronal population and
strongly decreased by ischemia indicating degeneration of photorecep-
tors (Figure 5b).
Next, we analyzed whether and how ischemia affected the ATP-
induced glutamate release from M€uller cells. In wildtype animals, the
glial glutamate release was only transiently reduced one day after the
insult and returned to a normal level at 7 d (Figure 6). In mice bearing
the dnSNARE transgene, glial ATP-induced glutamate release was con-
stantly lower compared with wildtype mice regardless of ischemia (Fig-
ure 6) except at 1 d after ischemia. The ischemic insult did not affect
the ATP-induced calcium response in M€uller cells from wildtype or
transgenic mice (Figure 6).
3.3 | Inhibition of glial SNARE-dependent release
reduces postischemic loss of neurons
Next, we studied how dnSNARE expression influenced pathologic
changes in postischemic retinae. A cardinal feature of the ischemia/
reperfusion model is the robust loss of neurons as shown by the reduc-
tion of rhodopsin (Figure 5b) and the thinning of retinal layers (Figure 7a,
b). While all morphological parameters (e.g., cell counts and IPL thickness)
investigated were not significantly different in untreated retinae of wild
type and dnSNARE mice (data not shown), our quantitative analysis
revealed that dnSNARE expression reduced the ischemia-induced loss of
cells in the nuclear layers and diminished the thinning of the inner plexi-
form layer (IPL) at different time points after surgery compared with
wildtype animals (Figure 7a,b). These findings were confirmed by TUNEL
staining of apoptotic cells. One day after surgery, when the neuronal cell
loss peaks (Kuroiwa et al., 1998), retinae from dnSNARE mice showed
significantly less apoptotic cells accross all layers compared with those
from wildtype littermates (Figure 7c). Since retinal ganglion cells and
amacrine cells are particularly susceptible to postischemic hyperexcita-
tion (Neufeld et al., 2002; Pannicke et al., 2014), we analyzed their den-
sity using immunohistochemical staining for the specific marker
calretinin (Figure 7d). Quantitative analysis revealed a reduced loss of
calretinin-expressing cells in the GCL 1 and 7 d after surgery in dnSNARE
mice compared with wildtype controls (Figure 7d). The loss of calretinin-
positive cells in the INL was also reduced except for the 7 d time point.
Together, these results indicated that expression of dnSNARE in M€uller
cells reduces the loss of neurons in specific retinal layers.
FIGURE 5.
F IGURE 5 Ischemia-induced changes in M€uller cells. (a)
Immunohistochemical (GFAP) and nuclear staining (TO-PRO-3) of
retinal slices from dnSNARE and wildtype mice 7 (d) days after
ischemia/reperfusion. Scale bar, 20 mm. (b) Top left, Mean
percentage of glutamine-synthetase (Glul) positive cells in retinal
cell suspensions from untreated (c) and postischemic (1 d (1), 7 d
(7); n52–3 independent experiments) retinae of wildtype and
transgenic mice that were subjected to magnetic-activated cell
sorting-based cell enrichment for M€uller cells. Neuronal fractions
(neurons) were depleted from M€uller cells. Other graphs in the
panel show the increase of indicated transcript levels in enriched
M€uller cells compared with the expression in the neuronal fraction
from the control eye. Note absence of glial and neuronal markers
from neuronal and glial preparations, respectively, the postischemic
loss of rhodopsin-positive photoreceptors and the upregulation of
GFAP-dependent transgenes. 888p< .001; 88p< .01; 8p< .05: signifi-
cant differences in transcript expression in M€uller cells compared
with the neuronal fraction from the same retinal condition. Values
were obtained from 4 to 6 independent experiments. Expression
levels for rhodopsin were normalized to the expression level in
M€uller cells isolated from untreated control retinae. All other genes
expression levels were normalized to the expression level in the
neuronal fraction from dnSNARE mice of untreated control eyes.
***p< .001, **p< .01, *p< .05. Inset shows micrographs of retinal
whole-mounts from a dnSNARE mice with a considerably larger
area of tissue being covered by EGFP-positive (green) M€uller cell
processes whereas glutamine synthetase (red) labeling is reduced
and diffuse in the postischemic retina. Scale bar, 20 mm [Color fig-
ure can be viewed at wileyonlinelibrary.com]
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To explore whether and how the dnSNARE transgene affected the
functional integrity of the postischemic retina, we recorded electroreti-
nograms (ERGs) (Figure 8). Control experiments confirmed that expres-
sion of the dnSNARE transgene in M€uller cells or its transient
suppression by administration of doxycycline did not affect ERG param-
eters (Figure 8a,b) confirming results obtained with inducible expression
of Botulinum neurotoxin B (iBot mice; Slezak et al., 2012). Transient
ischemia strongly reduced the a- and b-wave in wildtype mice already
14 hr after surgery, and this effect was much less pronounced in
dnSNARE mice retina (Figure 8c) indicating that dnSNARE expression
dampens the pathologic impairment of retinal light responses. However,
at 7 d after surgery, the visual responses disappeared in wildtype and
transgenic mice probably due to the loss of photoreceptors, which could
not be prevented by glial dnSNARE expression.
4 | DISCUSSION
In this study, we used a transgenic mouse model to investigate the
impact of glial SNARE-dependent exocytosis on postischemic neurode-
generation in the retina in vivo. We show that glia-specific inhibition of
SNARE-dependent signaling by dnSNARE expression reduces exocy-
totic release of glutamate from M€uller cells, impairs glial volume regula-
tion and protects retinal neurons from postischemic dysfunction and
degeneration, whereas ATP release by M€uller cells remained unaltered.
4.1 | Glia-specific dnSNARE expression inhibits
exocytotic transmitter release and impairs volume
regulation
Our findings validate dnSNARE mice as a tool to interfere with
SNARE-dependent processes in retinal glial cells. Immunohistochemical
staining of retinal sections (Figure 1) and transcript profiling revealed
that the transgene is exclusively present in glial cells (Figure 5b). The
human GFAP promoter fragment driving transgene expression faith-
fully recapitulated the activity of the endogenous GFAP promoter.
Notably, both promoters were activated by ischemia and caused a par-
allel increase of transcripts encoding GFAP and dnSNARE/EGFP (Fig-
ure 5b). Neuronal transgene expression previously reported in cortex
and hippocampus of dnSNARE mice (Fujita et al., 2014) was not
detectable in the retina indicating regional differences in the targeting
efficacy of transgenic lines (Pfrieger & Slezak, 2012).
Expression of the dnSNARE transgene reduced the amount of glu-
tamate release from M€uller cells regardless of its induction by calcium
(36% less release) or by ATP (48% reduction) (Figure 2a,f). These
results are similar to what was observed previously after glial expres-
sion of Botulinum neurotoxin serotype B (38% less) or pharmacological
blockade of vesicle loading with glutamate by application of bafilomy-
cin A1 (reduced by 31%; Slezak et al., 2012). In the end, a very consist-
ent reduction of glutamate release was measured in the three
independent experimental settings. This suggests that all approaches
(a) were similarly effective (quite likely close to 100% given the high
consistency of the results), (b) could hence serve as valuable tools to
analyze the impact of an absent glial exocytotic release. Moreover,
they corroborate the presence of glial glutamate release that is
SNARE-independent and mediated by alternative pathways (Hamilton
& Attwell, 2010; Montero & Orellana, 2015; Woo et al., 2012).
In concordance with Slezak et al. (2012), we also found that interfer-
ence with SNARE-dependent signaling impaired the ability of M€uller cells
to maintain their volume when challenged by hypotonic solution (Figure
4). Glutamate has been demonstrated to evoke release of ATP from
M€uller cells within the volume regulatory signaling cascade (Wurm et al.,
2008). Therefore, the block of swelling of EGFP-positive cells by gluta-
mate (Figure 4a) suggests that the release of ATP is not affected in
dnSNARE mice. This is in agreement with our direct measurements of
ATP release by single M€uller cells (Figure 3). The defect in volume regula-
tion was absent in M€uller cells that did not express the dnSNARE and the
EGFP transgenes. This particular pool of cells may prevent major morpho-
logical or functional alterations in retinae from transgenic mice. In particu-
lar, their presence may explain why light-evoked responses in ERGs
appear fairly normal in dnSNARE mice as well as in iBot mice (Slezak et al.,
2012) compared with wildtype animals. Taken together, two independent
genetic approaches to inhibit SNARE-dependent processes in glial cells
provide converging results, a partial inhibition of calcium-dependent gluta-
mate release from individual cells and impaired volume regulation.
4.2 | Contribution of SNARE-dependent processes to
postischemic neuronal dysfunction and degeneration
Using transcript analyses, ERGs and histochemical staining, we show
that transient ischemia/reperfusion impaired light-evoked responses in
the retina as early as 14 hr after surgery and caused massive degenera-
tion of photoreceptors and other types of retinal neurons within the
following days. Expression of dnSNARE in glial cells markedly reduced
the early defects in light-evoked responses of photoreceptors (a-wave)
FIGURE 6 Altered glutamate release from M€uller cells of the
postischemic retina. Left, mean sizes of ATP-induced glutamate
release (4 consecutive UV flashes) in single M€uller cells from trans-
genic and wildtype (wt) mice at the indicated conditions (c:
untreated; 0 hr: after 90 min ischemia, 1 and 7 d postischemia)
(n515–44 cells from 3 to 4 animals per group). **p< .01; *p< .05.
ADU5 arbitrary digital units. Right, mean amplitudes of ATP-
induced calcium responses (normalized to UV-flash induced
changes in the absence of NPE-ATP) in M€uller cells isolated from
untreated control eyes (c) or one day after transient ischemia (1)
from mice with indicated genotypes (n55–12 cells from 2 mice
per group). **p< .01; *p< .05
WAGNER ET AL. | 1067
and inner retinal cell types (b-wave) following ischemia. Obviously, the
functional integrity of retinal cells is highly sensitive to ischemic dam-
age and impaired long before cell loss. Our observation that transgene
expression protected neurons in the inner retina but not photorecep-
tors underline previous observations that among the retinal neurons,
ganglion and amacrine cells are most susceptible to glutamate-induced
hyperexcitation in the adult stage (Adachi et al., 1998; Lam, Abler, &
Tso, 1999). Under normal conditions, M€uller cells take up extracellular
glutamate by dedicated transporters such as the glutamate-aspartate
transporter (Bringmann et al., 2013; Rauen, 2000), which depend on a
negative membrane potential of M€uller glia (Brew & Attwell, 1987;
Bringmann et al., 2013; Sarantis & Attwell, 1990). Depolarization of
M€uller cell membranes by high extracellular potassium concentrations
in ischemic tissue impairs glutamate uptake (Billups & Attwell, 1996;
Maguire et al., 1998; Szatkowski, Barbour, & Attwell, 1990) ultimately
increasing extracellular glutamate levels. Cells highly susceptible to
glutamate-induced neurotoxicity die and thereby release large amounts
of ATP, which in turn aggravates the disastrous rise of extracellular glu-
tamate by triggering its release from M€uller glia. This process is prob-
ably interrupted by reduced glutamate release from M€uller cells
FIGURE 7 Reduction of neuronal cell loss by glial dnSNARE expression. (a) Right, Mean counts of DAPI-positive cell nuclei (left, see exem-
plary micrographs) in the indicated retinal layers at 14 hr and 7 (d) days after transient ischemia. (b) Mean thickness of the IPL at 14 hr and
7 d postsurgery. Cell number (a) and thickness (b) were normalized to values from the retina of the untreated contralateral eye (n54–5 sli-
ces from 3 to 11 animals per genotype and time point). *p< .05. (c) Left, Retinal sections subjected to TUNEL, nuclear (TO-PRO-3) and glu-
tamine synthetase staining to reveal M€uller cells. Grayscale micrographs show the TUNEL-signal. Right, mean counts of TUNEL-positive
cells at 1 d after transient ischemia normalized to total number of nuclei in the respective retinal layer (4–5 central retinal slices per animal;
5 animals per genotype). ···p< .001. (d) Left, Retinal sections subjected to nuclear (TO-PRO3) and calretinin staining—a marker of amacrine
cells in the INL and of ganglion cells and displaced amacrine cells in the GCL 1 d postsurgery. Note better preservation of calretinin-
positive dendrites extending into the IPL in postischemic retinae of dnSNARE mice. Right, mean counts of calretinin-positive cells in the
GCL and INL of retinal sections prepared 14 hr, 1 d, and 7 d postsurgery (4–5 central slices per animal, 3–11 animals per genotype). Values
were normalized to the number of cells found in the respective nonoperated contralateral eyes. ··p< .01; ·p< .05. ONL5outer nuclear layer
[Color figure can be viewed at wileyonlinelibrary.com]
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expressing the dnSNARE transgene. It has to be considered that
release of glutamate from glial cells is small compared with release
from presynaptic terminals. This is probably one of the reasons why
blockade of SNARE-dependent processes in glial cells cannot prevent
ultimate neuronal death in our ischemic model. Nevertheless, we
observe a transient amelioration in neuronal function and a delayed
loss of specific cells in dnSNARE mice revealing a contribution of
SNARE-dependent processes in glial cells to postischemic neuronal
dysfunction and degeneration. At present, we cannot exclude that
SNARE-dependent processes in glial cells other than glutamate release
have contributed to reduced neurodegeneration. We have demon-
strated that ATP release by M€uller cells is unaltered by dnSNARE
expression, however, a potential release of other gliotransmitters, for
example, D-serine, remains to be investigated.
FIGURE 8 Full-field ERGs from wildtype and dnSNARE mice. (a) Single flash ERG recordings from adult wildtype and dnSNARE mice
(n58 mice per genotype) under indicated conditions. Flash intensities are given as small numbers to the right of each trace and in (log
(cd*s/m2)). (b) Maximal amplitudes of scotopic light responses from dark-adapted untreated wildtype and dnSNARE mice (n54 mice per
genotype). Light responses of the same dnSNARE mice were measured at three consecutive time points (the arrow indicates direction of
the time line): before doxycycline administration (open bar), after two weeks of continuous doxycycline treatment (filled bar, via the drinking
water) and after wash-out of doxycycline (open bar again, normal drinking water for three weeks). (c) Mean amplitudes of a- and b-waves
recorded 14 hr and 7 d after transient ischemia in wildtype and dnSNARE mice. Values were normalized to maximal amplitudes recorded
from untreated contralateral eyes of each mouse (n56 mice per genotype) and are given with standard deviations. Inset, traces of light
responses to scotopic stimulation from eyes of wildtype and dnSNARE mice 14 hr after surgery. Flash intensities are given as small numbers
to the right of each trace and are given in [log (cd*s/m2)] [Color figure can be viewed at wileyonlinelibrary.com]
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Taken together our results reveal that dnSNARE expression in
M€uller cells protects retinal function in the early phase of ischemia and
reduces the loss of neurons in the inner retina although it remains to
be demonstrated whether there is a direct causal relationship between
glial transmitter exocytosis and neurodegeneration. These findings
emphasize the need to further investigate the role of SNARE-
dependent processes in glial cells under normal and pathological condi-
tions and to explore their potential as therapeutic targets.
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